CN102448485B - 免疫原性组合物及其用途 - Google Patents
免疫原性组合物及其用途 Download PDFInfo
- Publication number
- CN102448485B CN102448485B CN200980159611.8A CN200980159611A CN102448485B CN 102448485 B CN102448485 B CN 102448485B CN 200980159611 A CN200980159611 A CN 200980159611A CN 102448485 B CN102448485 B CN 102448485B
- Authority
- CN
- China
- Prior art keywords
- antigen
- cys
- pam
- dendritic cell
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/77—Ovalbumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPCT/AU2009/000446 | 2009-04-09 | ||
PCT/AU2009/000446 WO2010115229A1 (en) | 2009-04-09 | 2009-04-09 | Immunogenic composition and uses thereof |
PCT/AU2009/000469 WO2010115230A1 (en) | 2009-04-09 | 2009-04-16 | Immunogenic composition and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102448485A CN102448485A (zh) | 2012-05-09 |
CN102448485B true CN102448485B (zh) | 2015-01-14 |
Family
ID=42935575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980159611.8A Active CN102448485B (zh) | 2009-04-09 | 2009-04-16 | 免疫原性组合物及其用途 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20120064109A1 (zh) |
EP (2) | EP2946789B1 (zh) |
JP (1) | JP2012523379A (zh) |
CN (1) | CN102448485B (zh) |
CA (1) | CA2758204A1 (zh) |
WO (2) | WO2010115229A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008310313C1 (en) * | 2007-10-09 | 2015-02-12 | Ena Respiratory Pty Ltd | A method of transfection and compositions therefor |
US9676819B2 (en) | 2010-09-22 | 2017-06-13 | Innavac Pty Ltd | Immunostimulatory method |
US8883717B2 (en) | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
US9433671B2 (en) * | 2012-03-30 | 2016-09-06 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
US20170274068A1 (en) * | 2014-09-12 | 2017-09-28 | The University Of Melbourne | Immunological reagent |
BR112017013574A2 (pt) | 2014-12-23 | 2018-03-06 | Verdon Daniel | conjugados de aminoácido e peptídeo e usos dos mesmos |
US9968665B2 (en) | 2015-09-16 | 2018-05-15 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
SG11201807036QA (en) * | 2016-02-26 | 2018-09-27 | Auckland Uniservices Ltd | Amino acid and peptide conjugates and conjugation process |
WO2018176099A1 (en) | 2017-03-31 | 2018-10-04 | Ena Therapeutics Pty Ltd | Treatment of respiratory infection with a tlr2 agonist |
AU2018323043A1 (en) * | 2017-08-30 | 2020-03-05 | Auckland Uniservices Limited | Peptide conjugates, conjugation process, and uses thereof |
WO2020257870A1 (en) | 2019-06-26 | 2020-12-30 | Ena Therapeutics Pty Ltd | Novel molecules |
WO2023028649A1 (en) * | 2021-08-31 | 2023-03-09 | Ena Respiratory Pty Ltd | Allergy treatment |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005014040A3 (en) * | 2003-08-05 | 2005-04-28 | Royal Veterinary College | Antigen delivery system |
EP1666056A1 (en) * | 2004-12-06 | 2006-06-07 | Bestewil Holding B.V. | Cancer vaccine vesicles |
WO2006081631A1 (en) * | 2005-02-07 | 2006-08-10 | Lipotek Pty Ltd | Adjuvanting material |
CN1956729A (zh) * | 2004-05-21 | 2007-05-02 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗 |
CN101336291A (zh) * | 2005-12-08 | 2008-12-31 | 西北生物治疗药物公司 | 用于诱导未成熟单核细胞的树突细胞的激活的组合物和方法 |
CN101370513A (zh) * | 2005-12-23 | 2009-02-18 | 瓦克松生物技术公司 | 由肿瘤抗原衍生的优化隐蔽性肽组成的免疫原性多肽及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ518999A (en) * | 1999-11-19 | 2002-12-20 | Csl Ltd | Vaccine compositions |
CN1688606A (zh) | 2002-08-12 | 2005-10-26 | 昆士兰医学研究所理事会 | 含有辅助t细胞和b细胞表位的新的免疫原性脂肽 |
CN1688605B (zh) | 2002-08-12 | 2011-01-12 | 昆士兰医学研究所理事会 | 包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽 |
EP1550458A1 (en) | 2003-12-23 | 2005-07-06 | Vectron Therapeutics AG | Synergistic liposomal adjuvants |
EP2460533A3 (en) | 2004-10-18 | 2014-01-08 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
NZ556004A (en) | 2004-12-21 | 2010-05-28 | Vaxinnate Corp | Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein |
KR20080013850A (ko) | 2005-02-08 | 2008-02-13 | 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 | 면역원성 분자 |
WO2006091591A1 (en) | 2005-02-22 | 2006-08-31 | The Regents Of The University Of California | Methods of treating gastrointestinal inflammation |
US20080170996A1 (en) | 2006-07-28 | 2008-07-17 | The Board Of Regents Of The University Of Texas System | Compositions and Methods for Stimulation of Lung Innate Immunity |
AU2008310313C1 (en) * | 2007-10-09 | 2015-02-12 | Ena Respiratory Pty Ltd | A method of transfection and compositions therefor |
WO2009155332A1 (en) | 2008-06-17 | 2009-12-23 | Cedars-Sinai Medical Center | Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
EP2334332A4 (en) | 2008-09-05 | 2013-01-09 | Id Biomedical Corp Quebec | NEW COMPOSITIONS AND NEW ADJUVANTS |
MX2011008500A (es) | 2009-02-11 | 2011-09-26 | Univ California | Moduladores del receptor tipo toll y tratamiento de enfermedades. |
MX2011010050A (es) | 2009-03-25 | 2011-12-14 | Univ Texas | Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos. |
EP2338521A1 (en) | 2009-12-28 | 2011-06-29 | Helmholtz-Zentrum für Infektionsforschung GmbH | Lipopeptide- and lipoprotein-conjugates and its use |
-
2009
- 2009-04-09 WO PCT/AU2009/000446 patent/WO2010115229A1/en active Application Filing
- 2009-04-09 JP JP2012503830A patent/JP2012523379A/ja active Pending
- 2009-04-16 CN CN200980159611.8A patent/CN102448485B/zh active Active
- 2009-04-16 WO PCT/AU2009/000469 patent/WO2010115230A1/en active Application Filing
- 2009-04-16 EP EP15170809.6A patent/EP2946789B1/en active Active
- 2009-04-16 CA CA2758204A patent/CA2758204A1/en not_active Abandoned
- 2009-04-16 EP EP09842850.1A patent/EP2416801B1/en not_active Not-in-force
-
2011
- 2011-10-07 US US13/268,069 patent/US20120064109A1/en not_active Abandoned
-
2015
- 2015-01-22 US US14/602,778 patent/US9889195B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005014040A3 (en) * | 2003-08-05 | 2005-04-28 | Royal Veterinary College | Antigen delivery system |
CN1956729A (zh) * | 2004-05-21 | 2007-05-02 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗 |
EP1666056A1 (en) * | 2004-12-06 | 2006-06-07 | Bestewil Holding B.V. | Cancer vaccine vesicles |
WO2006081631A1 (en) * | 2005-02-07 | 2006-08-10 | Lipotek Pty Ltd | Adjuvanting material |
CN101336291A (zh) * | 2005-12-08 | 2008-12-31 | 西北生物治疗药物公司 | 用于诱导未成熟单核细胞的树突细胞的激活的组合物和方法 |
CN101370513A (zh) * | 2005-12-23 | 2009-02-18 | 瓦克松生物技术公司 | 由肿瘤抗原衍生的优化隐蔽性肽组成的免疫原性多肽及其用途 |
Non-Patent Citations (1)
Title |
---|
Andra et al.,."Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin- derived peptide".《Biochemical Journal》.2005,(第358期),第135–143页. * |
Also Published As
Publication number | Publication date |
---|---|
EP2416801A4 (en) | 2012-09-26 |
US20120064109A1 (en) | 2012-03-15 |
CN102448485A (zh) | 2012-05-09 |
US20150150966A1 (en) | 2015-06-04 |
US9889195B2 (en) | 2018-02-13 |
EP2946789A1 (en) | 2015-11-25 |
EP2946789B1 (en) | 2018-02-28 |
WO2010115229A1 (en) | 2010-10-14 |
EP2416801A1 (en) | 2012-02-15 |
EP2416801B1 (en) | 2015-07-22 |
JP2012523379A (ja) | 2012-10-04 |
CA2758204A1 (en) | 2010-10-14 |
WO2010115230A1 (en) | 2010-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102448485B (zh) | 免疫原性组合物及其用途 | |
Moyle et al. | Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines | |
CA2674269C (en) | Three component glycolipopeptides | |
CA2735724C (en) | Compositions and methods for treating influenza | |
Zeng et al. | Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys | |
JP2018510215A (ja) | 神経膠芽腫を治療するための細胞透過性ペプチド、カーゴ、及びtlrペプチドアゴニストを含む新規複合体 | |
Hamley | Peptides for vaccine development | |
Hamley | Lipopeptides for vaccine development | |
US20160199469A1 (en) | Oncology vaccine | |
JP5743315B2 (ja) | トランスフェクション方法及びそのための組成物 | |
JP2021130713A (ja) | 新規な免疫賦活法 | |
US10238747B2 (en) | Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof | |
KR20100138850A (ko) | 폴리감마글루탐산-키토산 나노입자를 함유하는 면역보강제 조성물 | |
Li et al. | Built-in adjuvants for use in vaccines | |
Zeng et al. | Lipidation of intact proteins produces highly immunogenic vaccine candidates | |
AU2019264673A1 (en) | Vaccine compositions and methods for restoring NKG2D pathway function against cancers | |
Roth et al. | Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes | |
Wijayadikusumah et al. | Structure–function relationships of protein–lipopeptide complexes and influence on immunogenicity | |
JP5931113B2 (ja) | 免疫原性組成物およびその使用 | |
CN115916253A (zh) | 半抗原化冠状病毒刺突蛋白 | |
AU2009344150B2 (en) | Immunogenic composition and uses thereof | |
Zeng et al. | Soluble Proteins Induce Strong CD8+ T Cell | |
BR112016008254B1 (pt) | Peptídeo que consiste em 4 epítopos de ctl ligados, composição de ctl, e composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170823 Address after: Victoria, Australia Patentee after: Innawak Pte. Ltd. Address before: Victoria, Australia Patentee before: THE University OF MELBOURNE |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Vitoria, Australia Patentee after: Ena Therapeutics Pty Ltd. Address before: Vitoria, Australia Patentee before: Innawak Pte. Ltd. Address after: Vitoria, Australia Patentee after: Axelia oncology Pte. Ltd. Address before: Vitoria, Australia Patentee before: Ena Therapeutics Pty Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221221 Address after: New South Wales,Australia Patentee after: Aina Breathing Pte. Ltd. Address before: Vitoria, Australia Patentee before: Axelia oncology Pte. Ltd. |
|
TR01 | Transfer of patent right |